In April, the Harvard Pilgrim Health Care Institute received a national Distinguished Clinical Research Award for its work to reduce methicillin-resistant Staphylococcus aureus (MRSA) in intensive care units. The Clinical Research Forum bestowed this honor on just three projects this year, citing them as outstanding examples of research projects that benefit the health and wellbeing of the general public.
The Institute’s study on antibiotic-resistant bacteria in hospitals demonstrated that using antimicrobial soap and ointment on all intensive care patients significantly cuts bloodstream infection. The study, published in New England Journal of Medicine in 2013, identified a change in health care practice that could help save lives.
The clinical trial involved nearly 75,000 patients in 43 community hospitals in 16 states, and highlights the potential to develop important insights as part of routine medical care. This collaborative effort involved several academic institutions, the Centers for Disease Control and Prevention (CDC), and Hospital Corporation of America (HCA).
Richard Platt, the senior investigator on the study, said, “It is a very great honor to have the MRSA study recognized as one of this year’s top clinical research studies by the Forum because of its national leadership in the field.”